Compare QRVO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QRVO | HSIC |
|---|---|---|
| Founded | 1957 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 9.1B |
| IPO Year | 1997 | 1995 |
| Metric | QRVO | HSIC |
|---|---|---|
| Price | $81.82 | $76.30 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 13 |
| Target Price | ★ $99.92 | $75.92 |
| AVG Volume (30 Days) | 1.0M | ★ 1.2M |
| Earning Date | 01-27-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.70 |
| EPS | 2.30 | ★ 3.17 |
| Revenue | $3,663,072,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $3.36 | $5.35 |
| Revenue Next Year | $2.39 | $3.34 |
| P/E Ratio | $34.94 | ★ $23.93 |
| Revenue Growth | N/A | ★ 3.51 |
| 52 Week Low | $49.46 | $60.56 |
| 52 Week High | $106.30 | $82.49 |
| Indicator | QRVO | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 51.07 |
| Support Level | $79.64 | $74.07 |
| Resistance Level | $89.37 | $80.03 |
| Average True Range (ATR) | 2.15 | 1.64 |
| MACD | -0.51 | -0.35 |
| Stochastic Oscillator | 22.40 | 37.42 |
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.